Resistance to bleomycin in cancer cell lines is characterized by prolonged doubling time, reduced DNA damage and evasion of G2/M arrest and apoptosis.
about
Pingyangmycin and Bleomycin Share the Same Cytotoxicity Pathway.Pharmacogenomics of second-line drugs used for treatment of unresponsive or relapsed osteosarcoma patients.Strain improvement by combined UV mutagenesis and ribosome engineering and subsequent fermentation optimization for enhanced 6'-deoxy-bleomycin Z production.Catalytic Metallodrugs: Substrate-Selective Metal Catalysts as Therapeutics.
P2860
Resistance to bleomycin in cancer cell lines is characterized by prolonged doubling time, reduced DNA damage and evasion of G2/M arrest and apoptosis.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Resistance to bleomycin in can ...... of G2/M arrest and apoptosis.
@ast
Resistance to bleomycin in can ...... of G2/M arrest and apoptosis.
@en
type
label
Resistance to bleomycin in can ...... of G2/M arrest and apoptosis.
@ast
Resistance to bleomycin in can ...... of G2/M arrest and apoptosis.
@en
prefLabel
Resistance to bleomycin in can ...... of G2/M arrest and apoptosis.
@ast
Resistance to bleomycin in can ...... of G2/M arrest and apoptosis.
@en
P2093
P2860
P1433
P1476
Resistance to bleomycin in can ...... of G2/M arrest and apoptosis.
@en
P2093
Dangxiao Cheng
Kangping Cui
Malcolm Moore
Osvaldo Espin-Garcia
Xiaoping Qiu
P2860
P304
P356
10.1371/JOURNAL.PONE.0082363
P407
P577
2013-12-04T00:00:00Z